Mobileye Leads Israeli IPO Rush as Deals Bypass Rockets
This article is for subscribers only.
Israel’s military showdown in the Gaza Strip is failing to deter its companies from trying to raise capital. Five are coming to market with U.S. initial public offerings in what’s poised to be a record week for new Israeli equity sales.
Mobileye NV is seeking to raise $638 million in what will be the biggest U.S. IPO ever by an Israeli company, valuing the Jerusalem-based maker of technology that helps stop car accidents at $4.9 billion. Four biotechnology companies, led by Vascular Biogenics Ltd., are raising a total of $223 million this week, according to data compiled by Bloomberg.